113 related articles for article (PubMed ID: 27288548)
1. Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis.
Yao J; Xie J; Xie B; Li Y; Jiang L; Sui X; Zhou X; Pan H; Han W
Biochem Pharmacol; 2016 Sep; 115():51-63. PubMed ID: 27288548
[TBL] [Abstract][Full Text] [Related]
2. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
3. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.
Chen Y; Wang B; Yuan X; Lu Y; Hu J; Gao J; Lin J; Liang J; Hou S; Chen S
Phytomedicine; 2021 Mar; 83():153489. PubMed ID: 33571919
[TBL] [Abstract][Full Text] [Related]
4. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth.
Li D; Zhang Y; Liu K; Zhao Y; Xu B; Xu L; Tan L; Tian Y; Li C; Zhang W; Cao H; Zhan YY; Hu T
Lab Invest; 2017 Nov; 97(11):1343-1353. PubMed ID: 28759012
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.
Bai B; Wu F; Ying K; Xu Y; Shan L; Lv Y; Gao X; Xu D; Lu J; Xie B
Theranostics; 2021; 11(13):6225-6239. PubMed ID: 33995655
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.
Huo X; Liu D; Gao L; Li L; Cao L
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.
Islam BN; Sharman SK; Hou Y; Bridges AE; Singh N; Kim S; Kolhe R; Trillo-Tinoco J; Rodriguez PC; Berger FG; Sridhar S; Browning DD
Cancer Prev Res (Phila); 2017 Jul; 10(7):377-388. PubMed ID: 28468928
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice.
Giner E; Recio MC; Ríos JL; Cerdá-Nicolás JM; Giner RM
Mol Nutr Food Res; 2016 Feb; 60(2):242-55. PubMed ID: 26502315
[TBL] [Abstract][Full Text] [Related]
10. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
[No Abstract] [Full Text] [Related]
11. An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer.
Kuai Y; Liu H; Liu D; Liu Y; Sun Y; Xie J; Sun J; Fang Y; Pan H; Han W
Theranostics; 2020; 10(15):6743-6757. PubMed ID: 32550901
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor.
Wei TT; Lin YT; Tseng RY; Shun CT; Lin YC; Wu MS; Fang JM; Chen CC
Clin Cancer Res; 2016 Aug; 22(16):4158-69. PubMed ID: 27528734
[TBL] [Abstract][Full Text] [Related]
13. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
14. Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel.
Im SA; Kim JW; Kim HS; Park CS; Shin E; Do SG; Park YI; Lee CK
Int Immunopharmacol; 2016 Nov; 40():428-435. PubMed ID: 27697726
[TBL] [Abstract][Full Text] [Related]
15. Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice.
Zielińska M; Szymaszkiewicz A; Jacenik D; Schodel L; Sałaga M; Zatorski H; Kordek R; Becker C; Krajewska WM; Fichna J
Eur J Pharmacol; 2020 Oct; 885():173463. PubMed ID: 32835668
[TBL] [Abstract][Full Text] [Related]
16. [Inflammation promotes the development of colitis-associated colorectal cancer].
He Z; Ke J; He X; Lian L; Sun L; Chen Z; Wu X; Lan P
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jul; 17(7):706-10. PubMed ID: 25070454
[TBL] [Abstract][Full Text] [Related]
17. Tea Polysaccharides Inhibit Colitis-Associated Colorectal Cancer via Interleukin-6/STAT3 Pathway.
Liu LQ; Nie SP; Shen MY; Hu JL; Yu Q; Gong D; Xie MY
J Agric Food Chem; 2018 May; 66(17):4384-4393. PubMed ID: 29656647
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
Front Immunol; 2021; 12():669747. PubMed ID: 34025672
[TBL] [Abstract][Full Text] [Related]
19. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
[TBL] [Abstract][Full Text] [Related]
20. Single probiotic supplement suppresses colitis-associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis.
Rong J; Liu S; Hu C; Liu C
J Gastroenterol Hepatol; 2019 Jul; 34(7):1182-1192. PubMed ID: 30357910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
